Netherlands· NL-025ee806f0e4

Perfan, concentraat voor oplossing voor infusie 5 mg/ml

A enoximone product containing enoximon, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 4 of our 19 countries.

ATC C01CE03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about enoximonAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Enoximone is registered in 4 of 19 countries.

Countries holding a registration under ATC C01CE03 (enoximone), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
1 of them publish a price we can compare per daily dose

Search enoximone products by name

Enoximone · ATC C01CE03

4 / 19 countries

Franceprice
Germany
Netherlands
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ENOXIMON
Manufacturer: Eureco-Pharma B.V.
Country: Netherlands (NL)
ATC code: C01CE03
ATC class: Enoximone
Defined daily dose: 1 g, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
135214//13343

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Enoximone in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enoximone products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

Germany · Perfan
France · Perfane
United Kingdom (Northern Ireland) · Perfan
Italy · Perfan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f41b9b42-93c4-48ab-a2d3-a65dc1bef728
GET /v1/drugs/f41b9b42-93c4-48ab-a2d3-a65dc1bef728?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h13343_smpc.pdf",
  "strength": null,
  "atc_label": "Enoximone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135214",
  "excipients": [
    "ETHANOL",
    "NATRIUMHYDROXIDE (E 524)",
    "PROPYLEENGLYCOL (E 1520)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ENOXIMON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135214.pdf",
  "authorised_at": "2025/07/07",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "135214//13343",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about enoximone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console